Molecular Glue Degraders for Non-Oncology Indications
Time: 9:00 am
day: Day 2 AM
Details:
- Molecular glue degraders (MGDs) have historically been developed for oncology indications
- Our platform has enabled programs in non-oncology indications, such as diseases associated with autoimmunity and inflammation
- An overview of the additional challenges associated with degraders for non-oncology diseases will be provided, together with updates on our programs highlighting our rational design of selective and orally active MGDs
